Day: May 7, 2021

The Board of Directors of Martela Corporation has decided on March 23, 2021 to establish a new share-based incentive plan for the group’s key employees. The decision on the share issue is based on the authorization by the Annual General Meeting of Shareholders held on 18 March 2021. The prerequisite for participating in the new plan is that a participant has acquired the company´s series A shares up to the number determined by the Board of Directors. In order to implement the plan, the Board of Directors decided on a share issue against payment directed to the target group. The company has published a stock exchange release on the plan and the related share issue on March 23, 2021. A maximum total of 359,000 new series A shares in the company were, in deviation from the shareholders’ pre-emptive right, offered in the share issue for subscription...

May 7, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on Friday, May 14, 2021 at 2:30 p.m. CET (8:30 a.m. ET) to discuss its first quarter 2021 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately one year following the call. Dial-in numbers:Please dial in 15 minutes prior to the live call. Belgium                 0800 389 13France                 0805 102 319Netherlands                0800 949 4506United Kingdom         0800 279 9489United...

VANCOUVER, British Columbia, May 07, 2021 (GLOBE NEWSWIRE) — Major Precious Metals Corp. (“Major Precious Metals” or the “Company”) (CSE:SIZE | OTC:SIZYF | FRANKFURT:3EZ) is pleased to announce the appointment of Anthony (Tony) J Williams as Chairman of the Company’s Board of Directors, and CEO. Tony Williams is the founder and Chairman of the Dragon Group (“Dragon”), a privately owned group of companies with a variety of interests in international mining finance and project management. Since establishing Dragon in 1995, Mr. Williams has brought multiple precious metal, base metal and diamond development projects through financing, successful construction, and ultimately production. These projects span across many jurisdictions including Africa, Central and South America, the former Soviet Union and Eastern and Northern Europe. Prior...

SAN CARLOS, Calif., May 06, 2021 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the outcome of the U.S. Food and Drug Administration (“FDA”) Arthritis Advisory Committee (“Committee”) on avacopan for the treatment of Antineutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis (or AAV). In the final part of the public meeting, the Committee voted on three questions presented by the FDA:The Committee vote split 9-9 on the first question, whether the efficacy data support approval of avacopan for the treatment of adult patients with AAV (granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)). On the second question, the Committee voted 10-8 that the safety profile of avacopan is adequate to support approval of avacopan for the treatment of adult patients with AAV (GPA and MPA).  In...

BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune and metabolic disorders, today announced the pricing of its initial public offering of 8,825,000 shares of common stock at a price to the public of $17.00 per share. All shares are being offered by Talaris. The gross proceeds to Talaris from the offering, before deducting underwriting discounts, commissions and other offering expenses, are expected to be approximately $150.0 million. The shares are expected to begin trading on The Nasdaq Global Select Market under the ticker symbol “TALS” on May 7, 2021. The offering...

HIGHLANDS RANCH, Colo., May 06, 2021 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced the pricing of its underwritten follow-on public offering of 4,000,000 shares of its common stock at a public offering price of $6.00 per share. The aggregate gross proceeds to Vivos from the public offering are expected to be $24 million prior to deducting underwriting discounts, commissions, and other estimated offering expenses. Vivos has granted the underwriters a 45-day option to purchase up to an additional 600,000 shares of common stock to cover over-allotments, if any. Roth Capital Partners is acting...

NEW YORK, NY, May 06, 2021 (GLOBE NEWSWIRE) — Golden Arrow Merger Corp. (the “Company”) announced today that the underwriters of its previously announced initial public offering of units have exercised their over-allotment option in full, resulting in the issuance of an additional 3,750,000 units at a public offering price of $10.00 per unit. After giving effect to the exercise and close of the option, an aggregate of 28,750,000 units have been issued in the initial public offering and an aggregate of $287,500,000 has been deposited in the Company’s trust account. The Company also announced that commencing on May 7, 2021, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock and redeemable warrants included in the units. No fractional warrants...

TORONTO, May 06, 2021 (GLOBE NEWSWIRE) — Yooma Wellness Inc. (“Yooma“) (CSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that it has awarded options and deferred share units for an aggregate of 5,662,831 common shares of the company (“Shares“) to its directors, officers, employees and consultants under the Long Term Incentive Plan (“LTIP“) approved by the shareholders of Yooma at shareholder meetings on January 25, 2021. The purpose of the grants is to properly incentivize key personnel and align their interests with those of the company. The grants included 5,455,000 options for Shares issued to officers, employees and consultants of Yooma with exercise prices of $1.24/Share, which will expire...

Company continues more than 100-year history of issuing cash dividend Detroit, May 06, 2021 (GLOBE NEWSWIRE) — DETROIT, May 6, 2021 (NYSE: DTE) — The DTE Energy Board of Directors declared a $1.085 per share dividend on its common stock payable July 15, 2021 to shareholders of record at the close of business June 21, 2021. This continues DTE Energy’s consistent dividend history, having issued a cash dividend for more than 100 years. “Our shareholders place a high value on our dividend and the role DTE plays in delivering consistent above-average returns,” said Jerry Norcia, DTE Energy president and CEO. “DTE’s continued dividend performance supports all of our stakeholders.” About DTE Energy   DTE Energy (NYSE: DTE) is a Detroit-based diversified energy company involved in the development and management...